Insmed INSM
NASDAQ INSM
$118.43 +2.33 (+2.01%)
As of: Nov 10, 2026 · 1:35 PM EST

Insmed (INSM) Acquisitions (2021)

Updated

Insmed (INSM) reported Acquisitions of -$216,000 for Q4 2021.

Analysis

Insmed (INSM) Acquisitions (2021) Analysis & Trends

For FY2021, Insmed posted Acquisitions of $6.7 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -17.15 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 10.59 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Insmed 25.82 Bn 20.86 Bn 446.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -216,000.00
API Access

Insmed Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=INSM&period=max&api_key=YOUR_API_KEY